In this review the existing evidence on the impact of Rashtriya Swasthya Bima Yojana (RSBY) is discussed in the context of international literature available on health insurance. We describe potential pathways through which health insurance can affect health and economic outcomes, discuss evidence from other developing countries, and identify potential biases and inconsistencies in existing studies on RSBY impact. Given the relatively recent introduction of RSBY, lack of quality, verifiable data on utilization patterns, and the absence of reliable evaluation studies, there is a need to exercise caution while assessing the merits of the programme.
The Need for Better Evidence to Evaluate the Health & Economic Benefits of India’s Rashtriya Swasthya Bima Yojana
rindam Nandi, E. Phoebe Holtzman, Anup Malani, Ramanan Laxminarayan